Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybuprocaine vs Bupivacaine for Intravitreal Injection Anesthesia
NCT05069350Phase 1Completed
- Sponsor
- Research Institute of Ophthalmology
- Start
- Sep 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxybuprocaine and bupivacaine in acute pain, sponsored by Research Institute of Ophthalmology. Primary endpoint: Verbal Numerical Rating Scale at 10 minutes. Started Sep 2021; status: completed.
02
Drugs
oxybuprocainebupivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05069350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05069350.